ARTICLE SUMMARY:
Three early-stage companies, Comphya, ExSeed, and Contraline, shed light on the reproductive issues that many men experience but few discuss openly.
Despite male reproductive physiology, including disorders thereof, being well understood by the medical community, the socially ingrained notion that sexual function and fertility are hallmarks of masculinity is inimical to the self-perception of men going through such disorders. Feelings of shame can often prevent candid discussion of sexual health among patients of all ages, but earlier diagnosis and treatment could afford them more options with better potential outcomes. Apart from addressing disease, a major part of men’s health pertains to family planning, one of the most impactful decisions of a person’s life. Start-ups Comphya, ExSeed, and Contraline have made it their mission to tackle these challenges and see that they do not define or detract from anyone’s identity, autonomy, or self-worth.
